Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Daniel AletahaAndreas KerschbaumerKastriot KastratiChristian DejacoMaxime DougadosIain B McInnesNaveed SattarTanja Alexandra StammTsutomu TakeuchiMichael TraunerDésirée Mfm van der HeijdeMarieke VoshaarKevin L WinthropAngelo RavelliNeil BetteridgeGerd-Rüdiger R BurmesterJohannes W J BijlsmaVivian BykerkRoberto CaporaliErnest H S ChoyCatalin CodreanuBernard CombeMary K CrowMaarten P T de WitPaul EmeryRoy M FleischmannCem GabayMerete Lund HetlandKimmie L HyrichAnnaMaria IagnoccoJohn Dudley IsaacsJoel M KremerXavier MariettePeter A MerkelEduardo F MyslerPeter NashMichael T NurmohamedKarel PavelkaGyula PoorAndrea Rubbert-RothHendrik Schulze-KoopsAnja StrangfeldYoshiya TanakaJosef S SmolenPublished in: Annals of the rheumatic diseases (2022)
The document provides a comprehensive consensus on the use of IL-6 inhibition to treat inflammatory disorders to inform healthcare professionals (including researchers), patients, administrators and payers.